Lexpos News

Deadline upcoming Community Pharmacy England previously published updated guidance and support to help community pharmacy owners complete the Data Security and Protection Toolkit (DSPTK) 2026. Completing the Toolkit is how pharmacies make their annual information governance (IG) declaration. It is a mandatory requirement under the NHS Terms of Service and must be completed by 30th [...]

The post Data Security and Protection Toolkit 2026: Are you working through it? appeared first on Community Pharmacy England.

In response to a significant ongoing disruption to the supply of Ramipril 1.25mg capsules, a Serious Shortage Protocol (SSP) has been issued by the Department of Health and Social Care (DHSC). Effective today 22nd April 2026, SSP087 provides that where supplies are available, but the prescription is for more than one month’s supply the total quantity [...]

The post SSP for Ramipril 1.25mg capsules issued appeared first on Community Pharmacy England.

MHRA Class 4 Medicines Defect Notification: Hiprex 1g tablets (Doncaster Pharma Limited) Drug alert number: EL(26)A/20 Date issued: 22 April 2026 Doncaster Pharma Limited has informed the MHRA of an error related to the Braille embossing on the outer packaging of the above mentioned parallel imported batches of Hiprex 1 g tablets (POM). It was identified [...]

The post MHRA Class 4 Medicines Defect Notification: Hiprex 1g tablets (Doncaster Pharma Ltd) appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has today (21/04/2026) confirmed the following list of price concessions for April 2026: Drug Pack size Price concession Amantadine 100mg capsules 56 £2.86 Apixaban 5mg tablets 56 £2.80 Aripiprazole 30mg tablets 28 £1.74 Aspirin 75mg dispersible tablets 28 £2.83 Aspirin 75mg dispersible tablets 100 £10.10 Atomoxetine 60mg capsules [...]

The post April 2026 Price Concessions 2nd Update appeared first on Community Pharmacy England.

MHRA Class 2 Medicines Recall: Ramipril 10mg capsules (Crescent Pharma Limited) Drug alert number: EL(26)A/19 Date issued: 20 April 2026 Crescent Pharma Limited is recalling one batch of Ramipril 10mg Capsules as a precautionary measure due to a potential error at the manufacturing site. DMRC reference number: DMRC-39191133 Company name: Crescent Pharma Limited Medicine Details Ramipril [...]

The post MHRA Class 2 Medicines Recall: Ramipril 10mg capsules (Crescent Pharma Limited) appeared first on Community Pharmacy England.